Intraocular pressure increase associated with epsilon-aminocaproic acid therapy for traumatic hyphema
- PMID: 3177553
- DOI: 10.1016/0002-9394(88)90871-9
Intraocular pressure increase associated with epsilon-aminocaproic acid therapy for traumatic hyphema
Abstract
We treated five patients receiving epsilon-aminocaproic acid who demonstrated sudden and accelerated clot dissolution with accompanying increases in intraocular pressure 24 to 96 hours after discontinuing treatment. All of these patients required additional ocular hypotensive medications and one patient required anterior chamber washout for persistently increased intraocular pressure. These findings suggest that certain patients with hyphema may be at risk for significant intraocular pressure increases following cessation of epsilon-aminocaproic acid therapy.
Similar articles
-
Intraocular pressure increase associated with traumatic epsilon-aminocaproic acid therapy for traumatic hyphema.Am J Ophthalmol. 1989 May 15;107(5):568-70. doi: 10.1016/0002-9394(89)90521-7. Am J Ophthalmol. 1989. PMID: 2712150 No abstract available.
-
[Epsilon aminocaproic acid for management of traumatic hyphema with large blood clot in the anterior chamber].Harefuah. 1990 Nov 1;119(9):269-70. Harefuah. 1990. PMID: 2258114 Hebrew.
-
Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid.Ophthalmology. 1987 Oct;94(10):1232-7. doi: 10.1016/s0161-6420(87)80005-2. Ophthalmology. 1987. PMID: 3317180 Clinical Trial.
-
Hyphema.Optom Clin. 1993;3(2):27-40. Optom Clin. 1993. PMID: 8268694 Review.
-
Trabeculectomy for traumatic hyphema in sickle cell trait.Semin Ophthalmol. 2015 Jul;30(4):297-304. doi: 10.3109/08820538.2013.847108. Epub 2013 Nov 19. Semin Ophthalmol. 2015. PMID: 24251431 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources